ABSTRACT
INTRODUCTION
Recurrent spontaneous abortion (RSA) refers to three or more consecutive miscarriages and is one of the health problems that arouses medical and social impacts and interest. Many of the deleterious factors that contribute to the occurrence of RSA are highly complex and include genetics, endocrine, anatomical, immunological and idiopathic factors. These factors act separately or together in the selection of the conceptus at different stages, preventing fertilization and inhibiting implantation [1, 2] .
Among the immunological factors that contribute to RSA stands out the presence of anti-phospholipid antibodies (APA) like as anti-cardiolipin antibodies (aCL), anti-β 2 -glycoprotein I (aβ 2 -GPI) and lupus anticoagulants (LAC) [3] . These antibodies belong to different classes (IgM, IgG or both) and are considered independent risk factors for thrombotic events [4] . It is accepted that the positivity for just one of them is sufficient, along with clinical criteria, as predictive marker for thrombosis [5, 6] .
It is estimated that the rate of APA in the general population varies between 0.2% and 2%, but when present in pregnant women, the APA increase the risk of RSA [3, 7] . Several studies have reported a higher frequency of APA in cases of RSA, especially related to intrauterine fetal growth restriction and preeclampsia [7] [8] [9] [10] [11] [12] . However, the importance of the APA in RSA remains controversial [13, 14] . The aim of this study was to determine the frequency of aCL in women with previous history of RSA. 
METHODS

RESULTS
From a total of 294 pregnant women seen at the High-Risk Pregnancy Unit in the study period, 44 consecutive patients fulfilled the inclusion criteria. The mean age of the selected women was equal to 33.8±5.4 years (minimum: 22, maximum: 44, median: 34).
Among the 44 patients, 18 (40.9%) were reagent for aCL and 26 (59.7%) non-reagent. The difference between the mean age of these groups were not statistically significant (reagent: 34.6±5.8 years, nonreagent: 33.2±5.2 years, p=0.400). The number of abortions reported ranged from 2 to 6 and the mean of this number in pregnant women reagent for aCL was 3.5±1.1, while in non-reagent was 2.9±1.1 (p=0.081). (Table 1) Fourteen (77.8%) patients presented aCL IgM and six (33.2%), aCL IgG. Two (11%) women had both IgM and IgG aCL. The aCL antibody titers observed were compatible with low risk for pregnancy morbidity as proposed by manufacturer's package insert of the ELISA kit (DiaSorin, Italy). (Table 2 
DISCUSSION
Research carried out on RSA in the last decades has devoted special attention to the importance of aCL antibodies as a risk factor to reproductive failure. There is evidence that they affect approximately 10% of cases of RSA [7, 8, 12] . These antibodies are specific to phospholipids expressed on the cell membrane and contribute to early fetal loss, potentially acting in reducing trophoblastic implantation [15, 16] . The mean age of the selected pregnant women was higher than that observed in a recent study that compared women with and without previous history of RSA [17] . This finding is not surprising since women with a history of RSA tend to persist in attempts to conceive for longer.
The results reported here demonstrate that the prevalence of aCL is high in women with a history of RSA as more than 40% of them were shown to be reactive to these antibodies. These data are consistent with some studies [18, 19] but not corroborate others [20, 21] . These discrepancies may be due to several factors. It is possible that the lack of standardization of methods used to detect these antibodies contribute to the reported differences between this and the studies of Branch et al. [20] and Simpson et al. [21] . In addition, maternal thromboembolism when present can exert strong influence on the success of pregnancy obscuring the importance of aCL [22, 23] . Previous observations reported a higher frequency of aCL in women with a history of RSA [12, 23] . There are reports highlighting the importance of aCL in reproductive success in which they account for approximately 10% of cases of RSA [4, 8] . The difference between the mean number of abortions found among pregnant women reagent and non-reagent for aCL was not statistically significant, although there was a tendency to be higher in the reagent. Bearing in mind the small number of selected pregnant women and the p value, this result should be considered preliminary and must be confirmed by studies with larger number of patients or a metanalysis.
The percentage of aCL was high among pregnant women with previous history of RSA. More than three quarters of them had IgM aCL class, over one third had aCL IgG class and over 10% had both aCL classes. In all cases the aCL titers were compatible with low risk for pregnancy morbidity as proposed by manufacturer's package insert of the commercial kit used to detect aCL. These data seem to be in agreement with evidences showing no relationship between clinical manifestations and titers of aCL antibodies belonging to IgM class [6] .
The importance of aCL antibody classes in RSA is still under discussion but there is consensus on the contribution of each of these classes of aCL in reproductive success. However, it has been suggested that aCL IgG react with higher avidity and this may have important implications for the pathophysiology of these antibodies in RSA. Moreover, these differences arising from the IgM and IgG classes appear to influence the adopted therapy for women with previous history of RSA.
The results of this study must be considered as preliminary since it enrolled a small number of patients. However it adds more information about the importance of aCL as a risk factor for RSA. Although additional investigations enrolling a high number of patients from other Brazilian regions would be desirable to confirm the data here reported, it can be concluded that the frequency of aCL is elevated in women with a previous history of RSA, especially those with a higher number of fetal losses. 
